Sushila Kataria, Pooja Sharma, Manish Kumar Singh, Vikas Deswal, Kuldeep Kumar, Sazid Alam, Vaibhav Gupta, Rashmi Phogat, Smita Sarma, Nipun Patil, Rohit Dutt, Padam Singh, Renu Saxena, Naresh Trehan
BACKGROUND & OBJECTIVES: The COVID-19 pandemic has caused significant global morbidity and mortality. As the vaccination was rolled out with prioritization on healthcare workers (HCWs), it was desirable to generate evidence on effectiveness of vaccine in prevailing real-life situation for policy planning. The objective of the study was to evaluate the safety, effectiveness and immunogenicity of COVID-19 vaccination among HCWs in a tertiary care hospital. METHODS: This prospective observational study was undertaken on the safety, immunogenicity and effectiveness of the ChAdOx1 nCoV- 19 coronavirus vaccine (Recombinant) during the national vaccine roll out in January-March 2021, in a tertiary care hospital, New Delhi, India...
May 2022: Indian Journal of Medical Research